Evidence map›Paper›PMID 20186268›Full record

ArticlePLoS biology2010

Genomic responses to abnormal gene dosage: the X chromosome improved on a common strategy.

Xinxian Deng, Christine M Disteche

Abstract read
In one paragraph

Article in PLoS biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Sex-specific silencing of X-linked genes by Xist RNA.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xinxian DengDepartment of Pathology, University of Washington, Seattle, Washington, United States of America.
Christine M Disteche

Funding

Mouse X InactivationR01GM046883 · NIGMS · UNIVERSITY OF WASHINGTON · PI DISTECHE, CHRISTINE M. · 1992 to 2018
$5.9M
DOSAGE COMPENSATION OF THE ACTIVE X CHROMOSOME IN MAMMALSR01GM079537 · NIGMS · UNIVERSITY OF WASHINGTON · PI DISTECHE, CHRISTINE M. · 2007 to 2010
$1.2M
NIGMS NIH HHS GM046883NIGMS NIH HHS GM079537NIGMS NIH HHS R01 GM046883NIGMS NIH HHS R01 GM079537
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AneuploidyAnimalsGene DosageHumansX Chromosome

Identifiers

PMID20186268
PMCPMC2826375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.